Komori
Maeda Kosen (7821) · InitiativeRestated

Preventing the Spread of COVID-19 and Addressing Products and Services in the Post-COVID Era

First written in FY2020. 3 of 5 entries say "Restated". Latest entry: FY2022-Q2.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021-Q1RestatedFY2021-Q2 – FY2022-Q22020: 12021: 320212022: 12022
Same theme, other companies
Development and Proposal of Products and Services Addressing Infectious DiseasesA theme 34 companies write about · 1 as a headwind · 35 as a tailwind

10 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q2RestatedAnnual report

    「As orders for medical and hygiene supplies for COVID-19 measures remained firm, both sales and profit exceeded the levels of the same period of the previous year.」

    The company continues to provide medical and hygiene supplies for infectious disease control and secure orders and sales.
  2. FY2021-Q3RestatedAnnual report

    「Demand for spunbond in the industrial materials field recovered, while orders for medical and hygiene materials used in COVID-19 measures remained solid. As a result, sales and profit from nonwoven-related products both exceeded the year-earlier levels.」

    The company continues to provide medical and hygiene supplies for infectious disease control and secure orders and sales.
  3. FY2021-Q2RestatedAnnual report

    「Demand for spunbond in the industrial materials field recovered, while orders for medical and hygiene materials used in COVID-19 measures remained solid. As a result, sales and profit from nonwoven-related products both exceeded the year-earlier levels.」

    The company continues to provide medical and hygiene supplies related to infectious disease control and secure orders.
  4. FY2021-Q1AdvancedAnnual report

    「We have successfully developed an antiviral-treated nonwoven fabric for our in-house-produced nonwoven masks and have begun selling the new product “スプリトップガード” (an antiviral-treated mask). Going forward, we will continue to provide medical and hygiene supplies, including masks and gowns, as measures against infectious diseases during the COVID-19 pandemic.」

    The policy of preventing the spread of infection has taken concrete form through the development and launch of sales of antiviral-treated masks and the provision of medical and hygiene supplies such as masks and gowns.
  5. FY2020First statedAnnual report

    「Accordingly, we will give the highest priority to the health of our employees and the peace of mind, health and safety of our business partners, thoroughly implement appropriate measures to prevent the spread of infection, and do our utmost to secure orders and sales. In anticipation of the end of the COVID-19 pandemic, we will also provide markets and customers with products and services required by post-COVID society.」

    For the first time, the company has separately identified responding to COVID-19 as a priority issue and explicitly stated its policy of preventing the spread of infection, securing orders and sales, and providing products and services for the post-COVID era.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Maeda Kosen yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Preventing the Spread of COVID-19 and Addressing Products and Services in the Post-COVID Era | MAEDA KOSEN CO.,LTD. (7821) | Komori